Prodelphinidin B3
Prodelphinidin B3 is a proanthocyanidin compound that exhibits significant anti-tumor activity. Prodelphinidin B3 induces cell cycle arrest at the G1/G0 phase in PC-3 cells, activates caspase-3, and promotes apoptosis. Prodelphinidin B3 can induce the differentiation of leukemia cells and synergistically enhance retinoic acid (HY-14649)-induced granulocytic differentiation and sodium butyrate (HY-B0350A)-induced monocytic differentiation in HL-60 cells. Prodelphinidin B3 also possesses antioxidant activity. Prodelphinidin B3 is used in research on prostate cancer and leukemia.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 78362-05-7
- 화학식: C30H26O13
- 분자량:594.52
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
제품 설명
IC50 & Target
[1]|
Caspase-3 |
In Vitro
Prodelphinidin B3 (10-100 μM; 48 h) exhibits significant cytotoxic activity (IC50 < 50 μM) against PC-3 prostate cancer cells[1].
Prodelphinidin B3 (50 μM; 48 h) induces cell cycle arrest at G1/G0 phase in PC-3 cells (G1/G0 population increases from 62.88% to 74.50%, and S phase decreases from 16.06% to 8.67%)[1].
Prodelphinidin B3 (50 μM; 48 h) activates caspase-3 and induces apoptosis in PC-3 prostate cancer cells (caspase-3 activity increases by 1.8-fold compared to the control)[1].
Prodelphinidin B3 (4-12 μM; 5 days) induces Nitroblue Tetrazolium (NBT )-reducing activity in HL60 human myeloid leukemia cells; concentrations above 40 μM induce cell death[2].
Prodelphinidin B3 (4-8 μM; 5 days) enhances 0.03 μM retinoic acid (HY-14649)-induced granulocytic differentiation of HL60 cells[2].
Prodelphinidin B3 (4-8 μM; 5 days) enhances 0.2 mM sodium butyrate (HY-B0350A)-induced alpha-naphthyl butyrate esterase activity in HL60 cells[2].
Prodelphinidin B3 shows antioxidant activity in three in vitro chemical assays, with values of 10.04, 5.68, and 9.81 μmol TE/μmol in the ORAC, HPS, and LA assays, respectively[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PC-3 prostate cancer cells
-
Concentration:50 μM
-
Incubation Time:48 h
-
Result:Induced a G1/G0 phase population increase from 62.88% to 74.50% and an S phase fraction decrease from 16.06% to 8.67%, indicating partial cell cycle blockade at the G1/G0 phase.
-
Cell Line:PC-3 prostate cancer cells
-
Concentration:50 μM
-
Incubation Time:48 h
-
Result:Activated caspase-3 up to 1.8 times compared to the control, confirming that cell death was attributable to apoptosis.
-
Cell Line:HL60 human myeloid leukemia cells
-
Concentration:4, 6, 8 and 12 μM
-
Incubation Time:5 days
-
Result:Induced NBT-reducing activity and alpha-naphthyl butyrate esterase activity in HL60 human myeloid leukemia cells, promoting cell differentiation; concentrations above 40 μM induced cell death.
-
Cell Line:PC-3 prostate cancer cells
-
Concentration:0, 10, 25, 50, and 100 μM
-
Incubation Time:48 h
-
Result:Showed significant cytotoxic activity with IC50 values below 50 μM. Cytotoxic effects were clearly associated with the presence of the pyrogallol moiety of the B ring.
Chemical Information
-
CAS No. 78362-05-7
-
분자량 594.52
-
화학식 C30H26O13
-
SMILES
O[C@H]([C@@H](C1=CC(O)=C(C=C1)O)O2)CC(C2=C3[C@@H]4C5=C(C=C(C=C5O[C@@H]([C@H]4O)C6=CC(O)=C(O)C(O)=C6)O)O)=C(C=C3O)O
-
Synonyms
(4,8)-(+)-Gallocatechin-(+)-catechin
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
HL-60 granulocytic/neutrophil-like differentiation
HL-60 cells are a human promyelocytic leukemia cell model that can be induced toward granulocytic/neutrophil-like differentiation by DMSO, ATRA, or combined ATRA+DMSO treatment; differentiation is evaluated by morphology, reduced proliferation, CD11b gain, CD71 loss, phagocytosis, oxidative burst/NBT reduction, ROS formation, and, where relevant, NET-related assays. A literature-supported default protocol is 5 days of combined 1 µM ATRA plus 1% DMSO, because this condition produced neutrophil-like morphology, cell-cycle arrest, high CD11b positivity, low CD71 positivity, and increased phagocytic capacity compared with ATRA or DMSO alone in the cited study.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
순도&문서
References
[1]. Suda M, et al. Syntheses of procyanidin B2 and B3 gallate derivatives using equimolar condensation mediated by Yb(OTf)3 and their antitumor activities. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4935-9. [Content Brief]
[2]. Tamagawa K, et al. Proanthocyanidins from barley bran potentiate retinoic acid-induced granulocytic and sodium butyrate-induced monocytic differentiation of HL60 cells. Biosci Biotechnol Biochem. 1998 Aug;62(8):1483-7. [Content Brief]
[3]. Spreng S, et al. Quantitation of Key Antioxidants and Their Contribution to the Oxidative Stability of Beer. J Agric Food Chem. 2024 Jul 24;72(29):16423-16437. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)